[ad_1]
The EMA says the benefits of Tavneos no longer outweigh the risks for the treatment of active granulomatosis with polyangiitis.
Medscape News Europe
[ad_2]
Source link : https://www.medscape.com/viewarticle/new-data-lead-decision-revoke-autoimmune-disease-drug-2026a1000lut?src=rss
Author :
Publish date : 2026-06-26 16:15:00
Copyright for syndicated content belongs to the linked Source.